IPSEN - Buy-Back Programme - Art 5 Of MAR - Week 35 - 2025

2025-09-02 12:01:29

(MENAFN- GlobeNewsWire - Nasdaq) Aggregated presentation by day and by market
Statement of transactions in own shares from August 25 ^th to August 29 ^th 2025

Name of the issuer	Identity code of the issuer (Legal Entity Identifier)	Day of the transaction	Identity code of the financial instrument	Total daily volume (in number of shares)	Daily weighted average purchase price of the shares	Market (MIC Code)
IPSEN	549300M6SGDPB4Z94P11	25/08/2025	FR0010259150	300	116,2	AQEU
IPSEN	549300M6SGDPB4Z94P11	25/08/2025	FR0010259150	602	116,36478	CCXE
IPSEN	549300M6SGDPB4Z94P11	25/08/2025	FR0010259150	300	116,16733	TQEX
IPSEN	549300M6SGDPB4Z94P11	25/08/2025	FR0010259150	3 134	116,40348	XPAR
IPSEN	549300M6SGDPB4Z94P11	26/08/2025	FR0010259150	300	114,5	AQEU
IPSEN	549300M6SGDPB4Z94P11	26/08/2025	FR0010259150	600	115,2	CCXE
IPSEN	549300M6SGDPB4Z94P11	26/08/2025	FR0010259150	300	116,1	TQEX
IPSEN	549300M6SGDPB4Z94P11	26/08/2025	FR0010259150	3 077	115,57995	XPAR
IPSEN	549300M6SGDPB4Z94P11	27/08/2025	FR0010259150	300	116,9	AQEU
IPSEN	549300M6SGDPB4Z94P11	27/08/2025	FR0010259150	113	116,8	CCXE
IPSEN	549300M6SGDPB4Z94P11	27/08/2025	FR0010259150	3 400	117,35488	XPAR
IPSEN	549300M6SGDPB4Z94P11	28/08/2025	FR0010259150	600	117,9	CCXE
IPSEN	549300M6SGDPB4Z94P11	28/08/2025	FR0010259150	3 400	117,82	XPAR
IPSEN	549300M6SGDPB4Z94P11	29/08/2025	FR0010259150	300	116,4	AQEU
IPSEN	549300M6SGDPB4Z94P11	29/08/2025	FR0010259150	800	116,7625	CCXE
IPSEN	549300M6SGDPB4Z94P11	29/08/2025	FR0010259150	200	116,4	TQEX
IPSEN	549300M6SGDPB4Z94P11	29/08/2025	FR0010259150	3 228	117,06431	XPAR
			TOTAL	20 954	116,7608

Attachment

EN_IPSEN - Buy-back programme - Art 5 of MAR - Week 35_2025

MENAFN02092025004107003653ID1110006986

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.